SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-019881
Filing Date
2017-01-26
Accepted
2017-01-26 16:51:32
Documents
1
Group Members
CANAAN PARTNERS IX LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G AMENDMENT NO. 1 d318690dsc13ga.htm SC 13G/A 74682
  Complete submission text file 0001193125-17-019881.txt   76218
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89140 | Film No.: 17550378
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 203-855-0400
Canaan IX L.P. (Filed by) CIK: 0001538676 (see all company filings)

IRS No.: 981030624 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A